CHD8.md
... ...
@@ -20,7 +20,7 @@ timeline
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|-----------------------------------------|
22 22
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene|
23
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@reddyGeneticFunctionalDrivers2017]|
23
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC [@reddyGeneticFunctionalDrivers2017]|
24 24
|![BL](images/icons/BL_tier1.png) |1 |high-confidence BL gene [@grandeGenomewideDiscoverySomatic2019]|
25 25
26 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
CHST2.md
... ...
@@ -16,7 +16,7 @@ timeline
16 16
17 17
|Entity|Tier|Description |
18 18
|:------:|:----:|-----------------------------------------|
19
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
19
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
20 20
21 21
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
22 22
DCAF6.md
... ...
@@ -16,7 +16,7 @@ timeline
16 16
17 17
|Entity|Tier|Description |
18 18
|:------:|:----:|-----------------------------------------|
19
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
19
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
20 20
21 21
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
22 22
DDX10.md
... ...
@@ -15,7 +15,7 @@ timeline
15 15
16 16
|Entity|Tier|Description |
17 17
|:------:|:----:|-----------------------------------------|
18
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
18
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
19 19
20 20
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
21 21
DICER1.md
... ...
@@ -15,7 +15,7 @@ timeline
15 15
16 16
|Entity|Tier|Description |
17 17
|:------:|:----:|-----------------------------------------|
18
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
18
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
19 19
20 20
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
21 21
HRAS.md
... ...
@@ -16,7 +16,7 @@ timeline
16 16
|Entity|Tier|Description |
17 17
|:------:|:----:|-----------------------------------------|
18 18
|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established|
19
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
19
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
20 20
21 21
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
22 22
LIN54.md
... ...
@@ -14,7 +14,7 @@ timeline
14 14
15 15
|Entity|Tier|Description |
16 16
|:------:|:----:|-----------------------------------------|
17
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
17
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20
MAP4K4.md
... ...
@@ -14,7 +14,7 @@ timeline
14 14
15 15
|Entity|Tier|Description |
16 16
|:------:|:----:|-----------------------------------------|
17
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established|
17
+|![DLBCL](images/icons/DLBCL_tier2.png) |2-F |failed QC|
18 18
19 19
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
20 20